Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Learn how to use compound interest in your retirement planning, ensuring a comfortable and financially secure future.
23,811 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
A director at Arteris disclosed disposing over 20,000 shares, split between a gift and an open-market sale. Here’s ho...
Fans in and around Houston faced a wave of counterfeit FIFA gear tied to a multimillion-dollar crackdown. This guide ...
A patient investment fund quietly grabbed a multi-million stake in Masimo after a landmark deal. This article breaks ...
Red Cat Holdings faced a sharp price move after news about a government contract came with unclear value. This articl...
ExxonMobil vs Chevron: bigger revenue doesn’t always mean better value. This guide shows how to read beyond the top l...
MARA Holdings sold roughly 15,133 BTC for $1.1 billion to buy back convertible notes and trim debt, a move that reduc...
Casey’s General Stores prepares to report Q4 results after the bell, with analysts weighing margins in prepared foods...
A sobering look at how forged credentials can unlock access to your money. This guide shows how it happens, the costs...
Tesla fans and skeptics alike have watched the stock struggle even as leadership paints an upbeat picture. This artic...
Five insiders each owning at least 10% recently sold shares of V2X, Inc., totaling 2.55 million shares for about $173...
Investors are watching SpaceX like a rocket on countdown. This article translates historical IPO patterns into a six-...